CHAPTER 1. INTRODUCTION

• 1.1. RESEARCH METHODOLOGY
  • 1.1.1. ERC desk research
  • 1.1.2. ERC data synthesis
  • 1.1.3. Data validation and market feedback
  • 1.1.4. ERC data sources

CHAPTER 2. DIGITAL THERAPEUTICS MARKET OVERVIEW

• 2.1. DIGITAL THERAPEUTICS MARKET INTRODUCTION
• 2.2. GLOBAL DIGITAL THERAPEUTICS MARKET REVENUE AND GROWTH RATE, 2017-2025
  • 2.2.1. Global Digital Therapeutics Market Revenue (Million USD) and Growth Rate (%), (2017-2025)

CHAPTER 3. GLOBAL DIGITAL THERAPEUTICS MARKET BY END USER, 2017-2025

• 3.1. PATIENTS
• 3.2. PROVIDERS
• 3.3. PAYERS 18
• 3.4. GLOBAL DIGITAL THERAPEUTICS MARKET REVENUE BY END USER, 2017-2025
  • 3.4.1. Global Digital Therapeutics Market Revenue (Million USD) and Share (%) By End user, 2017-2025
  • 3.4.2. Patients Market Revenue and Growth Rate, 2017-2025
  • 3.4.3. Providers Market Revenue and Growth Rate, 2017-2025
  • 3.4.4. Payers Market Revenue and Growth Rate, 2017-2025

Note: Similar information coverage has been provided for other end user segment.

CHAPTER 4. GLOBAL DIGITAL THERAPEUTICS MARKET BY APPLICATION, 2017-2025

• 4.1. OBESITY 20
• 4.2. RESPIRATORY DISEASE
• 4.3. SMOKING CESSATION
• 4.4. GLOBAL DIGITAL THERAPEUTICS MARKET REVENUE BY APPLICATION, 2017-2025
  • 4.4.1. Global Digital Therapeutics Market Revenue (Million USD) and Share (%) By Application, 2017-2025
  • 4.4.2. Obesity Market Revenue and Growth Rate, 2017-2025
  • 4.4.3. Respiratory disease Market Revenue and Growth Rate, 2017-2025
  • 4.4.4. Smoking cessation Market Revenue and Growth Rate, 2017-2025

Note: Similar information coverage has been provided for other application segment.

CHAPTER 5. GLOBAL DIGITAL THERAPEUTICS MARKET BY REGION, 2017-2025

• 5.1. NORTH AMERICA
  • 5.1.1. U.S.
  • 5.1.2. Canada
  • 5.1.3. Mexico
• 5.2. EUROPE
  • 5.2.1. U.K.
  • 5.2.2. France
  • 5.2.3. Germany
  • 5.2.4. Italy
  • 5.2.5. Spain
  • 5.2.6. Rest of Europe
• 5.3. ASIA PACIFIC
  • 5.3.1. China
  • 5.3.2. Japan
  • 5.3.3. India
  • 5.3.4. Korea
  • 5.3.5. Rest of APAC
• 5.4. SOUTH AMERICA
  • 5.4.1. Brazil 23
  • 5.4.2. Rest of South America
• 5.5. REST OF THE WORLD
  • 5.5.1. Middle East
  • 5.5.2. Africa
• 5.6. GLOBAL DIGITAL THERAPEUTICS MARKET REVENUE BY REGION, 2017-2025
  • 5.6.1. Global Digital Therapeutics Market Revenue (Million USD) and Share (%) By Region, 2017-2025
  • 5.6.2. North America Market Revenue and Growth Rate, 2017-2025
  • 5.6.3. Europe Market Revenue and Growth Rate, 2017-2025
  • 5.6.4. Asia Pacific Market Revenue and Growth Rate, 2017-2025
  • 5.6.5. South America Market Revenue and Growth Rate, 2017-2025
  • 5.6.6. Rest of the World Market Revenue and Growth Rate, 2017-2025

CHAPTER 6. MARKET DETERMINANTS

• 6.1. MARKET DRIVERS
• 6.2. MARKET RESTRAINTS
• 6.3. MARKET OPPORTUNITIES
• 6.4. MARKET DETERMINANTS RADAR CHART

CHAPTER 7. GLOBAL DIGITAL THERAPEUTICS MARKET COMPETITION BY SERVICE PROVIDERS

• 7.1. GLOBAL DIGITAL THERAPEUTICS REVENUE AND SHARE BY SERVICE PROVIDERS (2017-2025)
  • 7.1.1. Global Digital Therapeutics Revenue (Million USD) and Share (%) by Service Providers (2017-2025)
• 7.2. DIGITAL THERAPEUTICS MARKET COMPETITIVE SITUATION AND TRENDS
  • 7.2.1. Digital Therapeutics Market Share (%) of Top 3 Service Providers
  • 7.2.2. Digital Therapeutics Market Share (%) of Top 5 Service Providers

CHAPTER 8. COMPANY PROFILES

• 8.1. PROPELLER
  • 8.1.1. Business Overview
  • 8.1.2. Company Basic Information
  • 8.1.3. Digital Therapeutics Product Details
  • 8.1.4. Propeller Digital Therapeutics Revenue and Gross Margin
• 8.2. AKILI
  • 8.2.1. Business Overview
  • 8.2.2. Company Basic Information
  • 8.2.3. Digital Therapeutics Product Details
  • 8.2.4. Akili Digital Therapeutics Revenue and Gross Margin
• 8.3. BIG HEALTH
  • 8.3.1. Business Overview
  • 8.3.2. Company Basic Information
  • 8.3.3. Digital Therapeutics Product Details
  • 8.3.4. Big Health Digital Therapeutics Revenue and Gross Margin
• 8.4. OMANDA
  • 8.4.1. Business Overview
  • 8.4.2. Company Basic Information
  • 8.4.3. Digital Therapeutics Product Details
  • 8.4.4. Omanda Digital Therapeutics Revenue and Gross Margin
• 8.5. PEAR THERAPEUTICS
  • 8.5.1. Business Overview
  • 8.5.2. Company Basic Information
  • 8.5.3. Digital Therapeutics Product Details
  • 8.5.4. Pear Therapeutics Digital Therapeutics Revenue and Gross Margin
• 8.6. COGNOA
  • 8.6.1. Business Overview
  • 8.6.2. Company Basic Information
  • 8.6.3. Digital Therapeutics Product Details
  • 8.6.4. Cognoa Digital Therapeutics Revenue and Gross Margin
• 8.7. WELLDOC
  • 8.7.1. Business Overview
  • 8.7.2. Company Basic Information
  • 8.7.3. Digital Therapeutics Product Details
  • 8.7.4. WellDoc Digital Therapeutics Revenue and Gross Margin
• 8.8. SONOFI
  • 8.8.1. Business Overview
  • 8.8.2. Company Basic Information
  • 8.8.3. Digital Therapeutics Product Details
  • 8.8.4. Sonofi Digital Therapeutics Revenue and Gross Margin
• 8.9. VOLUNTIS
  • 8.9.1. Business Overview
  • 8.9.2. Company Basic Information
  • 8.9.3. Digital Therapeutics Product Details
  • 8.9.4. Voluntis Digital Therapeutics Revenue and Gross Margin

CHAPTER 9. DIGITAL THERAPEUTICS MARKET VALUE CHAIN ANALYSIS

• 9.1. DIGITAL THERAPEUTICS INDUSTRIAL CHAIN ANALYSIS
• 9.2. CONSUMER ANALYSIS
  • 9.2.1. Consumer 1
  • 9.2.2. Consumer 2
  • 9.2.3. Consumer 3

The research report offers a comprehensive picture of the Digital Therapeutics market. The report initiates with the executive summary of the market that includes market definition, recent industry trends, and developments, strategies of the key players and wide product offerings. Moreover, the study explains the future opportunities and a sketch of the key participants actively operating in the market.

About Digital Therapeutics Market

Digital therapeutics is emerging as the new generation of digital healthcare that implements treatment programs to specific infirmity such as diabetes, heart disease, high blood pressure and pulmonary diseases like COPD. The key factors fueling the growth of global digital therapeutics market are increasing use of smartphones and growing number of internet users. This has led to the digitalization of healthcare and effective management of chronic diseases. According to Forbes, Propeller Health, manufactures sensors that can be attached to the inhaler of people suffering from chronic diseases. This sensor observes the usage of inhaler and provides feedback through a mobile app. In addition, digital therapeutics allows remote consultation to patients in a cost effective manner, which is another crucial factor contributing towards the growth of this market.

The research report is prepared based on the combination of qualitative as well as quantitative aspects. By thorough understanding, the report is fragmented by larger ratios. The report covers in-depth analysis with major factors such as drivers, restraints, opportunities, and challenges that influences the growth of the market. On the other hand, The Digital Therapeutics report presents data starting from the base year 2018, historical year: 2014-2018, estimated the year 2019 and Forecast year from 2019 to 2026.

The Digital Therapeutics market report offers the market size and estimates the forecast from 2019-2026. The forecast estimation is predicted based on the key regions that include North America, Europe, Asia Pacific, Middle East, South America, and the Middle East & Africa. Furthermore, the Digital Therapeutics report provides a deep emphasis on secondary tools used to document the report. PEST analysis, SWOT, Porter’s Five Forces, and others are considered by the analysts while preparing the report.

Scope and Segmentation of the Market

Based on Type

Product 1
Product 2

Based on Application

Obesity
Diabetes
Respiratory disease
CNS Disease
Smoking cessation
Others

Each segment of the Digital Therapeutics market is extensively evaluated in the research study. The segment analysis covered in the report aims at the key opportunities available in the Digital Therapeutics market report by leading segments. In addition, the research report offers market dynamics for the market that influences qualitative as well as quantitative research.

Research Methodology

The report follows a comprehensive and rigorous research methodology to provide you accurate estimates and forecasts of a particular market. The report provide estimates, forecast, and analysis primarily based on secondary research, primary interviews, in-house database and other free as well as paid sources. In addition, the research methodology we follow is a systematic approach in order to estimate and project the market sizing keeping in mind all the ongoing and upcoming trends of the market.

Competitive Landscape

Key players profiled in this report include (Sales Revenue, Price, Gross Margin, Main Products, etc.):

Propeller
Akili
Big Health
Omanda
Pear Therapeutics
Cognoa
WellDoc
Sonofi
Voluntis

Through the successive chapters on the company, profiles provide deep insights on players operating in the Digital Therapeutics market. It focuses on the financial outlook of the key players, the status of R&D, strategies adopted, expansion strategies, and many more. Analysts preparing the report have offered a detailed list of the strategic initiatives adopted by the Digital Therapeutics market participants by referring past records and designing strategies to be adopted in the coming years. This enables the key players to stay ahead in the competition.

Regional Landscape

The chapter on regional segmentation details the regional aspects of the Digital Therapeutics market. This chapter explains the regulatory framework that is likely to impact the overall market. It highlights the political scenario in the market and anticipates its influence on the Digital Therapeutics market. Moreover, the report focuses on value and volume at the regional level, company level, and level.

Chapters covered under this report include:

Chapter 1, describes the Digital Therapeutics market reports - market overview, executive summary, and market scope. Further, the report adds a support base to identify the information and pick in relation to the aforementioned market

Chapter 2, defines the research methodology based on primary as well as secondary research, secondary data sources, and assumptions & exclusions

Chapter 3, description of Digital Therapeutics market in terms of its product scope, opportunities, drivers, restraints, and market risks

Chapter 4, the report offers a company profile of the top manufacturers of Digital Therapeutics market with its sales, revenue, share, and others

Chapter 5 and 6, to narrow down the sales data at the country level with shares, revenue, sand sales from 2018-2026

Chapter 7, the Digital Therapeutics market data is published based on a regional level and to show the revenue, sales, and growth on basis of the base year 2018, historical year: 2014-2018, estimated the year 2019 and Forecast year from 2019 to 2026

Chapter 8, describes the Digital Therapeutics market sales channels, distributors, research findings, appendix, and among others.